Literature DB >> 15122732

Independence of the statistician who analyses unblinded data.

Jay P Siegel1, Robert T O'Neill, Robert Temple, Gregory Campbell, Mary A Foulkes.   

Abstract

This discussion considers arguments for and against separating responsibility for the unblinded interim analysis of a clinical trial from responsibility for trial management and modifications to the ongoing trial. The degree to which one or different statisticians carry out these responsibilities and thus the degree of statistician independence for the two activities can vary, but a sponsor should recognize that giving a single statistician both responsibilities might limit flexibility in managing the trial, particularly with respect to modifying an ongoing trial.

Mesh:

Year:  2004        PMID: 15122732     DOI: 10.1002/sim.1789

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Experiences and challenges in data monitoring for clinical trials within an international tropical disease research network.

Authors:  M Chen-Mok; M J VanRaden; E S Higgs; R Dominik
Journal:  Clin Trials       Date:  2006       Impact factor: 2.486

Review 2.  Protecting clinical trial participants and protecting data integrity: are we meeting the challenges?

Authors:  Susan S Ellenberg
Journal:  PLoS Med       Date:  2012-06-12       Impact factor: 11.069

Review 3.  Sharing interim trial results by the Data Safety Monitoring Board with those responsible for the trial's conduct and progress: a narrative review.

Authors:  Victoria Borg Debono; Lawrence Mbuagbaw; Lehana Thabane
Journal:  Trials       Date:  2017-03-09       Impact factor: 2.279

Review 4.  Factors influencing the statistical planning, design, conduct, analysis and reporting of trials in health care: A systematic review.

Authors:  Marina Zaki; Lydia O'Sullivan; Declan Devane; Ricardo Segurado; Eilish McAuliffe
Journal:  Contemp Clin Trials Commun       Date:  2022-01-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.